<html lang="en">
<head>
<meta charset="utf-8"/>
<title offset="798">Enolase</title>
<script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_SVG.js" type="text/javascript">
</script>
</head>
<body>
<h1>Enolase</h1>
<hr/>

<p><strong>Enolase</strong>, also known as <strong>phosphopyruvate hydratase</strong>, is a <a class="uri" href="metalloenzyme" title="wikilink">metalloenzyme</a> responsible for the catalysis of the conversion of <a class="uri" href="2-phosphoglycerate" title="wikilink">2-phosphoglycerate</a> (2-PG) to <a class="uri" href="phosphoenolpyruvate" title="wikilink">phosphoenolpyruvate</a> (PEP), the ninth and penultimate step of <a class="uri" href="glycolysis" title="wikilink">glycolysis</a>. The <a href="chemical_reaction" title="wikilink">chemical reaction</a> catalyzed by enolase is:</p>
<dl>
<dd>2-phospho-D-glycerate 

<math display="inline" id="Enolase:0">
<semantics>
<mo>⇌</mo>
<annotation-xml encoding="MathML-Content">
<ci>normal-⇌</ci>
</annotation-xml>
<annotation encoding="application/x-tex">
   \rightleftharpoons
  </annotation>
</semantics>
</math>

 phosphoenolpyruvate + H<sub>2</sub>O
</dd>
</dl>

<p>Enolase belongs to the family of <a href="lyase" title="wikilink">lyases</a>, specifically the hydro-lyases, which cleave carbon-oxygen bonds. The systematic name of this enzyme is <strong>2-phospho-D-glycerate hydro-lyase (phosphoenolpyruvate-forming)</strong>.</p>

<p>The reaction is reversible, depending on environmental concentrations of substrates.<a class="footnoteRef" href="#fn1" id="fnref1"><sup>1</sup></a> The optimum pH for the human enzyme is 6.5.<a class="footnoteRef" href="#fn2" id="fnref2"><sup>2</sup></a> Enolase is present in all tissues and organisms capable of glycolysis or <a href="fermentation_(biochemistry)" title="wikilink">fermentation</a>. The enzyme was discovered by Lohmann and <a href="Otto_Fritz_Meyerhof" title="wikilink">Meyerhof</a> in 1934,<a class="footnoteRef" href="#fn3" id="fnref3"><sup>3</sup></a> and has since been isolated from a variety of sources including human muscle and <a class="uri" href="erythrocytes" title="wikilink">erythrocytes</a>.<a class="footnoteRef" href="#fn4" id="fnref4"><sup>4</sup></a> In humans, deficiency of ENO1 is linked to hereditary <a href="haemolytic_anemia" title="wikilink">haemolytic anemia</a> while ENO3 deficiency is linked to <a href="glycogen_storage_disease" title="wikilink">glycogen storage disease</a> XIII.</p>
<h2 id="isozymes">Isozymes</h2>

<p>In humans there are three subunits of enolase, <a href="alpha-enolase" title="wikilink">α</a>, <a href="enolase_2" title="wikilink">β</a>, and <a href="ENO3" title="wikilink">γ</a>, each encoded by a separate gene that can combine to form five different <a class="uri" href="isoenzymes" title="wikilink">isoenzymes</a>: αα, αβ, αγ, ββ, and γγ.<a class="footnoteRef" href="#fn5" id="fnref5"><sup>5</sup></a><a class="footnoteRef" href="#fn6" id="fnref6"><sup>6</sup></a> Three of these isoenzymes (all homodimers) are more commonly found in adult human cells than the others:</p>
<ul>
<li>αα or non-neuronal enolase (NNE), which is found in a variety of tissues, including liver, brain, kidney, spleen, adipose. It is present at some level in all normal human cells. Also known as <a href="alpha-enolase" title="wikilink">enolase 1</a></li>
<li>ββ or muscle specific enolase (MSE). Also known as <a href="ENO3" title="wikilink">enolase 3</a>. This enzyme is largely restricted to muscle where it is present at very high levels in muscle</li>
<li>γγ or neuron-specific enolase (NSE). Also known as <a href="enolase_2" title="wikilink">enolase 2</a>. Expressed at very high levels in neurons and neural tissues, where it can account for as much as 3% of total soluble protein. It is expressed at much lower levels in most mammalian cells.</li>
</ul>

<p>When present in the same cell, different isozymes readily form heterodimers.</p>
<h2 id="structure">Structure</h2>

<p>Enolase has a molecular weight of 82,000-100,000 Daltons depending on the isoform.<a class="footnoteRef" href="#fn7" id="fnref7"><sup>7</sup></a><a class="footnoteRef" href="#fn8" id="fnref8"><sup>8</sup></a> In human <a href="alpha_enolase" title="wikilink">alpha enolase</a>, the two subunits are <a href="Antiparallel_(biochemistry)" title="wikilink">antiparallel</a> in orientation so that <a href="Glutamate" title="wikilink">Glu</a><sup>20</sup> of one subunit forms an ionic bond with <a href="Arginine" title="wikilink">Arg</a><sup>414</sup> of the other subunit.<a class="footnoteRef" href="#fn9" id="fnref9"><sup>9</sup></a> Each subunit has two distinct domains. The smaller N-terminal domain consists of three <a href="Alpha_helix" title="wikilink">α-helices</a> and four <a href="Beta_sheet" title="wikilink">β-sheets</a>.<a class="footnoteRef" href="#fn10" id="fnref10"><sup>10</sup></a><a class="footnoteRef" href="#fn11" id="fnref11"><sup>11</sup></a> The larger C-terminal domain starts with two β-sheets followed by two α-helices and ends with a barrel composed of alternating β-sheets and α-helices arranged so that the β-beta sheets are surrounded by the α-helices.<a class="footnoteRef" href="#fn12" id="fnref12"><sup>12</sup></a><a class="footnoteRef" href="#fn13" id="fnref13"><sup>13</sup></a> The enzyme’s compact, globular structure results from significant hydrophobic interactions between these two domains.</p>

<p>Enolase is a highly conserved enzyme with five active-site residues being especially important for activity. When compared to wild-type enolase, a mutant enolase that differs at either the Glu<sup>168</sup>, Glu<sup>211</sup>, <a href="Lysine" title="wikilink">Lys</a><sup>345</sup>, or Lys<sup>396</sup> residue has an activity level that is cut by a factor of 105.<a class="footnoteRef" href="#fn14" id="fnref14"><sup>14</sup></a> Also, changes affecting <a href="Histidine" title="wikilink">His</a><sup>159</sup> leave the mutant with only 0.01% of its catalytic activity.<a class="footnoteRef" href="#fn15" id="fnref15"><sup>15</sup></a> An integral part of enolase are two Mg<sup>2+</sup> cofactors in the active site, which serve to stabilize negative charges in the substrate.<a class="footnoteRef" href="#fn16" id="fnref16"><sup>16</sup></a><a class="footnoteRef" href="#fn17" id="fnref17"><sup>17</sup></a></p>

<p>Recently, moonlighting functions of several enolases, such as interaction with plasminogen, have brought interest to the enzymes' catalytic loops and their structural diversity.<a class="footnoteRef" href="#fn18" id="fnref18"><sup>18</sup></a><a class="footnoteRef" href="#fn19" id="fnref19"><sup>19</sup></a></p>
<h2 id="structural-studies">Structural studies</h2>

<p>As of late 2007, 27 <a href="tertiary_structure" title="wikilink">structures</a> have been solved for this enzyme, with <a href="Protein_Data_Bank" title="wikilink">PDB</a> accession codes , , , , , , , , , , , , , , , , , , , , , , , , , , and .</p>
<h2 id="mechanism">Mechanism</h2>

<p> Using isotopic probes, the overall mechanism for converting 2-PG to PEP is proposed to be an <a href="E1cb" title="wikilink">E1cb elimination reaction</a> involving a carbanion intermediate.<a class="footnoteRef" href="#fn20" id="fnref20"><sup>20</sup></a> The following detailed mechanism is based on studies of crystal structure and <a href="Chemical_kinetics" title="wikilink">kinetics</a>.<a class="footnoteRef" href="#fn21" id="fnref21"><sup>21</sup></a><a class="footnoteRef" href="#fn22" id="fnref22"><sup>22</sup></a><a class="footnoteRef" href="#fn23" id="fnref23"><sup>23</sup></a><a class="footnoteRef" href="#fn24" id="fnref24"><sup>24</sup></a><a class="footnoteRef" href="#fn25" id="fnref25"><sup>25</sup></a><a class="footnoteRef" href="#fn26" id="fnref26"><sup>26</sup></a><a class="footnoteRef" href="#fn27" id="fnref27"><sup>27</sup></a> When the substrate, 2-phosphoglycerate, binds to α-enolase, its carboxyl group coordinates with two magnesium ion cofactors in the active site. This stabilizes the negative charge on the deprotonated oxygen while increasing the acidity of the alpha hydrogen. Enolase’s Lys<sup>345</sup> deprotonates the alpha hydrogen, and the resulting negative charge is stabilized by resonance to the carboxylate oxygen and by the magnesium ion cofactors. Following the creation of the carbanion intermediate, the hydroxide on C3 is eliminated as water with the help of Glu<sup>211</sup>, and PEP is formed.</p>

<p>Additionally, conformational changes occur within the enzyme that aid catalysis. In human α-enolase, the substrate is rotated into position upon binding to the enzyme due to interactions with the two catalytic magnesium ions, <a href="Glutamine" title="wikilink">Gln</a><sup>167</sup>, and Lys<sup>396</sup>. Movements of loops <a href="Serine" title="wikilink">Ser</a><sup>36</sup> to His<sup>43</sup>, Ser<sup>158</sup> to <a href="Glycine" title="wikilink">Gly</a><sup>162</sup>, and <a href="Aspartate" title="wikilink">Asp</a><sup>255</sup> to <a href="Asparagine" title="wikilink">Asn</a><sup>256</sup> allow Ser<sup>39</sup> to coordinate with Mg<sup>2+</sup> and close off the active site. In addition to coordination with the catalytic magnesium ions, the pKa of the substrate’s alpha hydrogen is also lowered due to protonation of the phosphoryl group by His<sup>159</sup> and its proximity to Arg<sup>374</sup>. Arg<sup>374</sup> also causes Lys<sup>345</sup> in the active site to become deprotonated, which primes Lys<sup>345</sup> for its role in the mechanism.</p>
<h2 id="diagnostic-uses">Diagnostic Uses</h2>

<p>In recent medical experiments, enolase concentrations have been sampled in an attempt to diagnose certain conditions and their severity. For example, higher concentrations of enolase in <a href="cerebrospinal_fluid" title="wikilink">cerebrospinal fluid</a> more strongly correlated to low-grade <a class="uri" href="astrocytoma" title="wikilink">astrocytoma</a> than did other enzymes tested (<a class="uri" href="aldolase" title="wikilink">aldolase</a>, <a href="pyruvate_kinase" title="wikilink">pyruvate kinase</a>, <a href="creatine_kinase" title="wikilink">creatine kinase</a>, and <a href="lactate_dehydrogenase" title="wikilink">lactate dehydrogenase</a>).<a class="footnoteRef" href="#fn28" id="fnref28"><sup>28</sup></a> The same study showed that the fastest rate of tumor growth occurred in patients with the highest levels of CSF enolase. Increased levels of enolase have also been identified in patients who have suffered a recent <a href="myocardial_infarction" title="wikilink">myocardial infarction</a> or <a href="cerebrovascular_accident" title="wikilink">cerebrovascular accident</a>. It has been inferred that levels of CSF neuron-specific enolase, <a href="Blood_plasma" title="wikilink">serum</a> NSE, and creatine kinase (type BB) are indicative in the prognostic assessment of cardiac arrest victims.<a class="footnoteRef" href="#fn29" id="fnref29"><sup>29</sup></a> Other studies have focused on the prognostic value of NSE values in cerebrovascular accident victims.<a class="footnoteRef" href="#fn30" id="fnref30"><sup>30</sup></a></p>

<p><a class="uri" href="Autoantibodies" title="wikilink">Autoantibodies</a> to alpha-enolase are associated with the rare syndrome called <a href="Hashimoto's_encephalopathy" title="wikilink">Hashimoto's encephalopathy</a>.<a class="footnoteRef" href="#fn31" id="fnref31"><sup>31</sup></a></p>
<h2 id="inhibitors-of-enolase">Inhibitors of Enolase</h2>

<p>Small-molecule inhibitors of enolase have been synthesized as chemical probes of the catalytic mechanism of the enzyme. The most potent of these is phosphonoacetohydroxamate, which in its unprotonated form has pM affinity for the enzyme. It has structural similarity to the presumed catalytic intermediate, between PEP and 2-PG. Attempts have been made to use this inhibitor as an anti-trypanosome drug, and more recently, as an anti-cancer agent, specifically, in glioblastoma that are enolase-deficient due to homozygous deletion of the ENO1 gene as part of the 1p36 locus.</p>

<p><a class="uri" href="Fluoride" title="wikilink">Fluoride</a> is a known competitor of enolase’s substrate 2-PG. The fluoride is part of a complex with magnesium and phosphate, which binds in the active site instead of 2-PG.<a class="footnoteRef" href="#fn32" id="fnref32"><sup>32</sup></a> As such, drinking <a href="water_fluoridation" title="wikilink">fluoridated water</a> provides fluoride at a level that inhibits oral bacteria enolase activity. Disruption of the bacteria’s glycolytic pathway - and, thus, its normal metabolic functioning - prevents <a href="dental_caries" title="wikilink">dental caries</a> from forming.<a class="footnoteRef" href="#fn33" id="fnref33"><sup>33</sup></a><a class="footnoteRef" href="#fn34" id="fnref34"><sup>34</sup></a></p>
<h2 id="references">References</h2>
<ul>
<li></li>
<li>Boyer, P.D., Lardy, H. and Myrback, K. (Eds.), The Enzymes, 2nd ed., vol. 5, Academic Press, New York, 1961, p. 471-494.</li>
<li></li>
</ul>
<h2 id="external-links">External links</h2>
<ul>
<li></li>
</ul>

<p>"</p>

<p><a href="Category:Moonlighting_proteins" title="wikilink">Category:Moonlighting proteins</a></p>
<section class="footnotes">
<hr/>
<ol>
<li id="fn1"><a href="#fnref1">↩</a></li>
<li id="fn2"><a href="#fnref2">↩</a></li>
<li id="fn3">Lohman K &amp; Meyerhof O (1934) Über die enzymatische umwandlung von phosphoglyzerinsäure in brenztraubensäure und phosphorsäure (Enzymatic transformation of phosphoglyceric acid into pyruvic and phosphoric acid). Biochem Z 273, 60–72.<a href="#fnref3">↩</a></li>
<li id="fn4"></li>
<li id="fn5"></li>
<li id="fn6"><a href="#fnref6">↩</a></li>
<li id="fn7"></li>
<li id="fn8"></li>
<li id="fn9"></li>
<li id="fn10"></li>
<li id="fn11"></li>
<li id="fn12"></li>
<li id="fn13"></li>
<li id="fn14"></li>
<li id="fn15"></li>
<li id="fn16"></li>
<li id="fn17"></li>
<li id="fn18"><a href="#fnref18">↩</a></li>
<li id="fn19"><a href="#fnref19">↩</a></li>
<li id="fn20"><a href="#fnref20">↩</a></li>
<li id="fn21"></li>
<li id="fn22"><a href="#fnref22">↩</a></li>
<li id="fn23"><a href="#fnref23">↩</a></li>
<li id="fn24"><a href="#fnref24">↩</a></li>
<li id="fn25"><a href="#fnref25">↩</a></li>
<li id="fn26"><a href="#fnref26">↩</a></li>
<li id="fn27"><a href="#fnref27">↩</a></li>
<li id="fn28"><a href="#fnref28">↩</a></li>
<li id="fn29"><a href="#fnref29">↩</a></li>
<li id="fn30"><a href="#fnref30">↩</a></li>
<li id="fn31"><a href="#fnref31">↩</a></li>
<li id="fn32"></li>
<li id="fn33"><a href="#fnref33">↩</a></li>
<li id="fn34"><a href="#fnref34">↩</a></li>
</ol>
</section>
</body>
</html>
